About Optonome
Optonome is a Healthcare company based in Philadelphia (United States) founded in 2014. Real-time data tracking and analysis are enabled via app platform. Its Indian entity Thar Commercial Finance Private Limited reported revenue of ₹55.98 Cr. Its focus areas include HealthTech, Healthcare IT, Provider and Professional Network. Its competitors include Therapeutic Research Center, QuantiaMD and DocMatter; 2 of its 3 listed competitors have raised funding.
Company details
Optonome was founded in 2014 in Philadelphia, United States, within the health technology sector. An app-based platform is utilized for managing personal data, including moods, behaviors, support plans, eating habits, and sleep patterns. These elements are monitored in real-time, with collected data subjected to analysis for generating relevant health insights and recommendations. Operations focus on user-driven data handling across mobile devices.
- Headquarters Philadelphia, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website optonome.com
- Social LinkedIn Facebook
- Legal Name Thar Commercial Finance Private Limited
- Date of Incorporation 25 Jul, 2008
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹55.98 Cr
FY 2025 · +7% YoY
- Indian entity net profit₹5.93 Cr
FY 2025 · 11% margin
- Indian entity EBITDA₹48.21 Cr
FY 2025 · 86% margin
Associated legal entities of Optonome
Optonome operates through Thar Commercial Finance Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Thar Commercial Finance Private Limited CIN U65999MH2008PTC185082 | Active | 25 Jul 2008 | Mumbai, Maharashtra | ₹56.0 Cr | 4 | View details |
Funding Insights of Optonome
- Total Rounds 1
All 1 funding rounds of Optonome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | Seed | – | – | – |
Board of directors of Thar Commercial Finance Private Limited (Optonome)
Thar Commercial Finance Private Limited is the primary company behind Optonome. The board of Thar Commercial Finance Private Limited currently have 3 directors; the longest-serving is Vivek Jayesh Thar, appointed in 2015. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Jayesh Thar DIN 06812365 | Director | 21 Feb 2015 | 11 yrs 8 mo | Thar Commercial Finance Private Limited |
| Chintan Hitendra Shah DIN 01376629 | Director | 21 Jan 2019 | 7 yrs 9 mo | Thar Commercial Finance Private Limited |
| Yatin Ajitrai Mankad DIN 00786683 | Director | 10 May 2021 | 5 yrs 6 mo | Thar Commercial Finance Private Limited |
People of Optonome
1 people are tracked at Optonome (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dennis D. | Founder & CEO | Leadership |
Complete people profiles for Optonome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Optonome
Figures of Thar Commercial Finance Private Limited, the primary company behind Optonome, for FY 2025. Revenue was ₹55.98 Cr (+7% year on year). Net profit was ₹5.93 Cr (11% margin). EBITDA was ₹48.21 Cr (86% margin). Revenue has grown at a compounded annual rate of +9% over three years and 0% over five years.
- ₹55.98 CrRevenue · FY 2025 · +7% YoY
- ₹5.93 CrNet profit · 11% margin
- ₹48.21 CrEBITDA · 86% margin
- ₹49.96 CrPaid-up capital
- +9%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Thar Commercial Finance Private Limited are on its company page.
Detailed financial statements for Optonome
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Optonome
2 dated milestones of Optonome across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Optonome is founded.
- Funding First funding round.
Competitors of Optonome
Optonome has 3 listed competitors in our database, 2 of them funded. They include Therapeutic Research Center, QuantiaMD and DocMatter.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| trchealthcare.com | 1985 | Stockton, United States | Provides medication learning through concise news, unbiased recommendations, and relevant educational services | |||
| quantiamd.com | 2004 | Waltham, United States | $37.98M | 1,578 | Online community for physicians | |
| docmatter.com | 2012 | San Francisco, United States | $8.54M | 56 | An online platform is offered for collaboration among healthcare professionals. |
Detailed competitors of Optonome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Optonome (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Optonome
Complete news archive for Optonome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optonome
Optonome was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Optonome is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
The primary company behind Optonome, Thar Commercial Finance Private Limited, reported revenue of ₹55.98 Cr for FY 2025, up 7% year on year.
Optonome was founded in 2014 in Philadelphia, United States, within the health technology sector. An app-based platform is utilized for managing personal data, including moods, behaviors, support plans, eating habits, and sleep patterns. These elements are monitored in real-time, with collected data subjected to analysis for generating relevant health insights and recommendations. Operations focus on user-driven data handling across mobile devices.
Optonome's top competitors include Therapeutic Research Center, QuantiaMD and DocMatter.
Optonome operates through Thar Commercial Finance Private Limited.
The legal entities of Optonome currently have 4 directors, including Yatin Ajitrai Mankad, Vivek Jayesh Thar, Chintan Hitendra Shah and others.